Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
47 Leser
Artikel bewerten:
(0)

Nonmydriatic Handheld Fundus Camera Market Worth $186.4 Million by 2025: Grand View Research, Inc.

SAN FRANCISCO, December 11, 2018 /PRNewswire/ --

The global nonmydriatic handheld fundus camera market size is expected to reach USD 186.4 million by 2025, according to a new report by Grand View Research, Inc., registering a 9.1% CAGR during the forecast period. Increasing geriatric population has resulted in higher prevalence of age-related macular degeneration (AMD). Furthermore, rising incidence of diabetic retinopathy is expected to increase demand for ophthalmic screening devices, subsequently driving demand for nonmydriatic handheld fundus cameras.

(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )

According to laws and regulations by various medical devices agencies in U.S. as well as Japan, fundus imaging cameras must be replaced once in every four years. Hence, demand for these devices is likely to increase in these developed countries in the coming years. Supportive government regulations such as these are likely to have a positive impact on the nonmydriatic handheld fundus camera market.

Approximately 80.0% cases of blindness due to chronic diseases can be avoided by continuous and effective screening. Screening is the only way of detecting eye diseases at an early stage. In U.S., fundus photography procedures are covered by Medicare under CPT code 92250. Growing insurance coverage for such procedures is also likely to boost demand for handheld fundus cameras.

Browse full research report with TOC on "Nonmydriatic Handheld Fundus Camera Market Analysis Report By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2018 - 2025"at:https://www.grandviewresearch.com/industry-analysis/nonmydriatic-handheld-fundus-camera-market

Further Key Findings From the Report Suggest:

  • Demand for portable fundus cameras is expected to grow at a rapid rate due to its ergonomic design and user convenience. This is expected to contribute to the growth of the nonmydriatic handheld fundus camera market
  • According to the National Eye Institute, the number of people suffering from diabetic retinopathy, aged 40 and above, in U.S. is estimated to reach 11.4 million by 2030
  • North America held a majority market share in 2017 due to increasing prevalence of vision related disorders, growing awareness about their treatments, and technological advancements in digital medical devices
  • Government initiatives being undertaken for quality, affordable, and speedy healthcare delivery are likely to drive the market. Medicare, for instance, covers the cost of cataract surgery, ocular prosthesis, and glaucoma screening
  • Increasing number of product approvals in U.S. has led to adoption of improved technologies by ophthalmologists. For instance, Topcon Medical Systems received clearance for 3D OCT-1 Maestro from the U.S. FDA in July 2016
  • Asia Pacific is anticipated to be one of the fastest growing regional markets over the forecast period due to presence of a large patient pool, improved healthcare services, and increasing medical tourism in the region
  • Some of the key companies active in the market are Topcon Medical Systems, Inc.; Carl Zeiss Meditec Group; Optomed Oy (Ltd.); OptoVue, Inc.; NIDEK Co., Ltd.; Canon, Inc.; and Clarity Medical Systems, Inc.

Browse related reports by Grand View Research:

  • Fundus Cameras Market - The global fundus cameras market size was valued at USD 347.6 million in 2015 and is projected to grow at a CAGR of 6.8% over the forecast period.
  • Home Infusion Therapy Market - The global home infusion therapy market size was valued at USD 13.0 billion in 2015.
  • Brain Tumor Diagnosis And Therapeutics Market - The global brain tumor diagnosis and therapeutics market was valued at USD 354.9 million in 2015 and is expected to grow at a CAGR of 8.1% over the forecast period.
  • Mammography Market - The global mammography market size was valued at USD 1.43 billion in 2015 and is projected to grow at a CAGR of 10.5% during the forecast period.

Grand View Research has segmented the global nonmydriatic handheld fundus camera market based on region:

  • Nonmydriatic Handheld Fundus Camera Region Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
    • Asia Pacific
      • Japan
      • China
    • Latin America
      • Brazil
      • Mexico
    • Middle East & Africa
      • South Africa

Explore the BI enabled intuitive market research database,Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com


© 2018 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.